Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

A recent study reveals that 60% of liver cancer cases are preventable by addressing key risk factors such as viral hepatitis, ...

Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

Higher cumulative exposure to uric acid is independently and dose-dependently associated with an increased risk for MASLD. Cumulative uric acid (UA) exposure is an independent risk factor for ...